FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models

por O’Farrell, Marie, Duke, Greg, Crowley, Richard, Buckley, Douglas, Martins, Eduardo B., Bhattacharya, Dipankar, Friedman, Scott L., Kemble, George
Publicado 2022

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

por Gordon, Stuart C, Krastev, Zahary, Horban, Andrzej, Petersen, Jörg, Sperl, Jan, Dinh, Phillip, Martins, Eduardo B, Yee, Leland J, Flaherty, John F, Kitrinos, Kathryn M, Rustgi, Vinod K, Marcellin, Patrick
Publicado 2013

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

por Buti, Maria, Tsai, Naoky, Petersen, Joerg, Flisiak, Robert, Gurel, Selim, Krastev, Zahary, Aguilar Schall, Raul, Flaherty, John F., Martins, Eduardo B., Charuworn, Prista, Kitrinos, Kathryn M., Mani Subramanian, G., Gane, Edward, Marcellin, Patrick
Publicado 2014

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

por Buti, Maria, Fung, Scott, Gane, Edward, Afdhal, Nezam H., Flisiak, Robert, Gurel, Selim, Flaherty, John F., Martins, Eduardo B., Yee, Leland J., Dinh, Phillip, Bornstein, Jeffrey D., Mani Subramanian, G., Janssen, Harry L. A., George, Jacob, Marcellin, Patrick
Publicado 2015

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019

por Serrano Jr., Carlos V., Soeiro, Alexandre de M., Leal, Tatiana C. A. Torres, Godoy, Lucas C., Biselli, Bruno, Hata, Luiz Akira, Martins, Eduardo B., Abud-Manta, Isabela C. K., Tavares, Caio A. M., Cardozo, Francisco Akira Malta, de Oliveira Jr., Múcio Tavares
Publicado 2019